A retrospective analysis of veristrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancer
- 浏览0
Journal of thoracic oncology
443-451页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



